Back to search

Article

Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection

2023-02-19

Abstract excerpt

From December 2022 to January 2023, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections caused by BA.5 and BF.7 subvariants of B.1.1.529 (Omicron) swept across mainland China. It is crucial to estimate the protective effect of the neutralizing antibodies generated by such mass infections against the next potential SARS-CoV-2 reinfection wave, especially if driven by CH.1.1 or XBB.1.5. Previousl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5ce11b6c-43a4-552e-b59b-4b485f728ccc
DOI
10.1101/2023.02.14.527605
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfectionDOI 10.1101/2023.02.14.527605
Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective studySemantic proximity
Occurrence and significance of Omicron BA.1 infection followed by BA.2 reinfectionSemantic proximity
Evasion of neutralizing antibodies by Omicron sublineage BA.2.75Semantic proximity
Title of the article: Current Review of the SARS-CoV-2 Omicron Subvariant BF.7 (BA.5.2.1.7) Virology and Preventing Strategies.Semantic proximity
Neutralization of SARS-CoV-2 BQ.1.1 and XBB.1.5 by Breakthrough Infection Sera from Previous and Current Waves in ChinaSemantic proximity
Clinical Virology and Effect of Vaccination and Monoclonal Antibodies against SARS-CoV-2 Omicron Sub Variant BF.7 (BA.5.2.1.7): A systematic reviewSemantic proximity
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariantsSemantic proximity
Variant-specific antibody correlates of protection against SARS-CoV-2 Omicron symptomatic and overall infectionsSemantic proximity
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by 4 doses of parental mRNA vaccine or a BA.5-bivalent boosterSemantic proximity
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5Semantic proximity
Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2Semantic proximity
Vaccine- and BTI-elicited pre-Omicron immunity more effectively neutralizes Omicron sublineages BA.1, BA.2, BA.4 and BA.5 than pre-Omicron infection aloneSemantic proximity
Select a neighboring publication to make it the new centre.